used mainly for the treatment avapro and glucosamine hypertension. Irbesartan may also delay progression of diabetic nephropathy and is also indicated for the treatment of hypertension. Irbesartan was developed by Sanofi Research (now part of sanofi-aventis). It is jointly marketed by sanofi-aventis and Bristol-Myers.

is indicated for the reduction of renal disease progression in patients with nephropathy due to avapro and glucosamine 2 diabetes.". N Engl J Med 345 (12): avapro and glucosamine PMID 11565517.^ Rossi S, editor. Australian Medicines Handbook; 2006. ISBN 0-9757919-2-3 IrbesartanFrom Wikipedia, the free encyclopedia(Redirected from Avapro)Jump to: navigation, searchIrbesartanSystematic (IUPAC) name2-butyl-3-[p-(o-1H-tetrazol-5-ylphenyl)benzyl]-1,3-diazaspiro[4.4]non-1-en-4-oneIdentifiersCAS number 138402-11-6ATC code C09CA04PubChem 3749DrugBank APRD00413Chemical dataFormula C25H28N6OMol. mass 428.53SMILES eMolecules & PubChemPharmacokinetic dataBioavailability avapro and glucosamine Hepatic (CYP2C9)Half life 11–15 hoursExcretion Renal 20%, faecal 65%Therapeutic considerationsLicence data EU, USPregnancy cat. D (Au)Legal status S4 (Au), POM (UK), ?-only avapro and glucosamine OralIrbesartan (INN) (pronounced /?rb??s?rt?n/) is an angiotensin II receptor antagonists, irbesartan avapro and glucosamine indicated for the treatment of hypertension. Irbesartan avapro and glucosamine developed Irbesartan.

names to irbesartan preparations, including CoAprovel, Karvezide, Avalide and Avapro HCT.[edit].